Editor’s Update and Selected Articles From the Journal of the Neurological Sciences

By John D. England, MD

John D. England

John D. England

The editorial staffs of the Journal of the Neurological Sciences (JNS) and our publisher, Elsevier, have strived to enhance the quality of the journal. I am pleased to inform you that Elsevier soon will introduce the Journal Workflow Modernization Programme. This new workflow program, which Elsevier has named LeMans, will result in authors receiving proofs of their articles within 24 to 72 hours after acceptance. The LeMans program will significantly decrease the production time for all of our accepted articles. As an editor, I know that authors desire to see their articles published as quickly as possible, and this new feature will accelerate the publication process.

Additional steps for enhancing publication such, as the introduction of Article-Based Publishing (ABP) are planned. ABP, which should be introduced in late 2015, will post articles online as soon as they are finalized without waiting for an entire journal issue to be compiled.

All of these advancements reflect the ongoing transition from print to electronic publishing. JNS, like many Elsevier journals, is moving quickly toward a totally electronic publishing platform.

In our ongoing attempt to enhance accessibility of JNS articles for members of the World Federation of Neurology (WFN), we have selected two more free-access articles, which are profiled in this issue of World Neurology.

  1. Stephanie Brown and Andrew Stanfield provide an excellent review of the fragile X tremor ataxia syndrome (FXTAS), which is an increasingly recognized movement disorder. Affected individuals carry the permutation allele of the FMR1 gene. This permutation is an expansion of the nontranslated 5′ CGG repeat region of FMR1 from the normal range, which is less than 45 repeats to between 55 and 200 repeats. Affected individuals are usually men over 50 years of age who have progressive symptoms of tremor, ataxia and cognitive decline. Other manifestations include Parkinsonism, peripheral neuropathy, autonomic dysfunction and endocrine changes. The authors detail the clinical, molecular and neuroimaging manifestations of the disease. They emphasize the neuroimaging characteristics of FXTAS, which include increased T2 signal intensity in the middle cerebellar peduncle (MCP sign), thinning of the corpus callosum and white matter atrophy.

Brown SSG, Stanfield AC. Fragile X premutation carriers: A systematic review of neuroimaging findings. J Neurol Sci 2015;352:19-28.

  1. Alexander Slade and Sinisa Stanic reviewed the literature regarding the usefulness of salivary gland irradiation for managing sialorrhea in patients with amyotrophic lateral sclerosis (ALS). Many patients with ALS have difficulty controlling salivary secretions. Although oral anticholinergic medications or botulinum toxin injected into the salivary glands can be helpful, patient intolerance or unacceptable adverse effects may occur. This review concludes that the majority of ALS patients with sialorrhea respond well to salivary gland irradiation and experience minimal side effects. Thus, clinicians should consider this treatment option for patients with ALS who are troubled by excessive salivation.

Slade A, Stanic S. Managing excessive saliva with salivary gland irradiation in patients with amyotrophic lateral sclerosis. J Neurol Sci 2015;352:34-36.

John D. England, MD, is editor-in-chief of the Journal of the Neurological Sciences.

Candidate Recommendations for WFN Election 2015

The Nominating Committee of the World Federation of Neurology (WFN), having invited nominations for one treasurer and one elected trustee post, both to be filled with effect from the 2015 Annual General Meeting (Council of Delegates) on Nov. 1, recommended the following candidates to the membership:

Treasurer

  • Prof. Richard Stark (Australia)
  • Prof. Andreas Steck (Switzerland)

Elected Trustee

  • Prof. Morris Freedman (Canada)
  • Prof. Steven Lewis (United States)

In accordance with Article 6.3 of the WFN Memorandum & Articles of Association, allowing for additional candidates who are supported by five or more authorized delegates from other member societies, Dr. Daniel Truong (United States) also will contest the post of elected trustee.

World Brain Day 2015 Focuses on Epilepsy

By Mohammad Wasay, MD, FRCP, FAAN

A World Federation of Neurology (WFN) initiative has transformed into a collaborative movement between the World Health Organization, the International League Against Epilepsy and the International Bureau of Epilepsy. This year, July 22 marked a special day in the history of neurology advocacy.

National societies prepared activities, including press conferences, media briefings, CME seminars, public awareness gatherings, awareness walks, epilepsy camps and various other activities for individuals with epilepsy and their families. National neurology societies collaborated with national epilepsy societies and patient support groups for World Brain Day activities.

The WFN Public Awareness and Advocacy Committee prepared a World Brain Day poster, brochure and PowerPoint presentation for media briefing. Banners for display on websites and Facebook pages also were available for promotion of this global activity. Press releases were issued in many languages to all major global newspapers and news agencies.

The main objective of World Brain Day is to promote brain health by preventing and caring for neurological diseases. This year’s theme was epilepsy. All of our awareness campaigns were dedicated toward epilepsy care.

The goal was to reach about 100 million people around globe through these multilingual, multimedia campaign jointly organized by WFN, the World Health Organization, International League Against Epilepsy and International Bureau for Epilepsy.

Mohammad Wasay, MD, FRCP, FAAN, is chair of the Public Awareness and Advocacy Committee.

World Federation of Neurology Teaching Centers

The World Federation of Neurology (WFN) has established Teaching Centers for training young neurologists in Africa. The first Teaching Center opened at the Department of Neurology of Mohamed V. Souissi University in Rabat in 2014, and now also the Department of Neurology of Cairo University will participate.

The WFN will offer a three-year training course in Rabat (French speaking), and a one-year training course in Cairo (English speaking), starting in September 2015. The WFN will cover travel costs, tuition and a monthly allowance for living expenses for this period.

Persons from Africa can apply for a teaching course in either Rabat or Cairo, according to the conditions and criteria specified on the WFN website.

To apply, applicants must submit their CV, a supporting statement indicating which training program they wish to apply for and a letter of recommendation from the dean of their department by Friday, July 3, 2015, by email to enkanagu@kenes.com. The applications will be accepted from Friday, May 15, 2015, until Friday, July 3, 2015. A commission of the WFN will select the most suitable candidates. For more information on the training programs, the selection criteria and the process, visit the WFN website: www.wfneurology.org.

 

 

Epilepsy: Theme for World Brain Day 2015

By Mohammad Wasay and Wolfgang Grisold

WBD-logo

Scenic Santiago, Chile, is the host city for the Congress

Epilepsy is one of the most common neurological diseases in world with an estimated more than 50 million people affected around world. It affects people of all ages. Almost 50 percent have a cause for these epileptic seizures, including stroke, brain trauma, infections, tumors or brain damage during or before delivery of a baby. It may cause three to six times increase risk of premature death. More than 80 percent live in developing countries, and almost 70 percent do not receive any treatment. Stigma and discrimination are important aspects of this treatable disease. More than 70 percent of people with epilepsy can lead a normal life with treatment. These were the facts and figures that inspired the World Federation of Neurology to select “epilepsy” as a theme for 2015 World Brain Day campaign.

2015 is a landmark year in history of epilepsy. The World Health Assembly adopted the resolution, titled “Global burden of epilepsy and the need for coordinated actions at the country level to address its health, social and public knowledge implications.” This resolution is a call for action from member countries and stakeholders.

The World Brain Day campaign will be jointly organized by WFN, the International League Against Epilepsy (ILAE) and the International Bureau of Epilepsy (IBE). Both of these organizations have been working for decades to improve public awareness, doctors’ training and advocacy. We urge our delegate societies to work with local ILAE and IBE chapters to organize World Brain Day 2015 activities. Our campaign will focus on prevention of epilepsy.

The Public Awareness and Advocacy Committee is in the process of preparing publicity material for this campaign. The material will include logos, banner ads for websites, handbills, brochures, posters, billboards and presentations. There will be a press conference in collaboration with the World Health Organization. A multilanguage press release will be prepared and circulated to delegate societies.

The most important target of this campaign is the public. We need to create simple messages in local languages and promote them via electronic, social media, billboards, banner and events. The next important area of intervention is health care authorities and policymakers. Our campaign should result in policy and priority shifts at the national or local level. We have to plan targeted activities to facilitate this outcome. Another important area of intervention is awareness and training of general practitioners, nurses and paramedical staff. Involvement of media is a must. Celebrities, scientists and sports figures with epilepsy could be a part of this advocacy campaign.

World Brain Day 2014 was a great success due to participation of large number of delegate national societies organizing activities and media events. Hundreds of newspaper items and media posts were created and shared via electronic, print and social media.

World Brain Day 2015 will be extremely productive in spreading the message all around globe, not only to affected people, doctors and health care authorities but to those normal, healthy people who are at risk for developing epilepsy. We can defeat epilepsy by awareness and effective treatment.

Wasay is the chair of the Public Awareness and Advocacy Committee.

Editor’s Update and Selected Articles from the Journal of Neurological Sciences (JNS)

By John D. England

John D. England, MD

John D. England, MD

On April 21, 2015, the Editorial Board of the Journal of the Neurological Sciences (JNS) met in Washington, DC. I’m pleased to report that by all measures JNS has shown steady and healthy growth. The number of manuscripts that are submitted to the journal has continued to increase over the past several years. Specifically, 1,718 manuscripts were submitted and reviewed in 2014, compared to 1,520 in 2013. Additionally, the number of full text article downloads via Science Direct increased from 764,832 in 2013 to 807,404 in 2014.

By all current indicators, these numbers are expected to increase for 2015. Because JNS is the official journal of the World Federation of Neurology (WFN), the Editorial Board welcomes submissions from around the world. As a measure of this aim, JNS receives articles from authors and institutions around the globe. The majority of submissions come from Asia, Western Europe and North America (U.S. and Canada).

As a reflection of the continuing globalization of science and technology, the journal has seen a significant increase in the number of papers from Eastern Europe, the Middle East and Africa. Although a new impact factor (IF) for the journal will not be calculated until later in 2015, we are hopeful that these positive trends will also result in an increase in the IF over the next few years.

In our ongoing attempt to enhance accessibility of JNS articles to WFN members, we have selected two more “free-access” articles, which are profiled in this issue of World Neurology. These articles are paired and are presented together.

1) Apostolos Safouris, et al, provide an interesting and instructive case description of an older man with probable Alzheimer’s disease who presented with an episode of acute motor aphasia, which was initially diagnosed as a transient ischemic attack (TIA). Although an initial brain CT-scan did not demonstrate an acute lesion, a gradient-echo MRI performed within the first 48 hours revealed a left cortical parietal microbleed (MB). The authors argue persuasively that the MB was probably responsible for the patient’s symptoms and was likely associated with cerebral amyloid angiopathy (CAA). The authors suggest that patients with known or probable CAA (especially those with Alzheimer’s disease) not undergo thrombolysis or anticoagulation for a possible ischemic stroke until amyloid-associated MB is excluded. Safouris A, Gazagnes M-D, Triantafyllou N, Tsivgoulis G. Cerebral amyloid angiopathy-associated microbleed mimicking transient ischemic attack. J Neurol Sci 2015;351:198-199.

2) In an accompanying editorial, Andreas Charidimou provides a succinct and useful perspective on cerebral amyloid disease. He points out that sporadic cerebral amyloid angiopathy (CAA) is a common neuropathological finding in the aging brain, and it is especially notable in the brains of individuals with Alzheimer’s disease. CAA is an important risk factor for spontaneous lobar intracerebral hemorrhage and anticoagulant — associated brain hemorrhage. Dr. Charidimou points out that transient focal neurological spells, sometimes called “amyloid spells,” are well described and probably more common than is generally appreciated. Since these transient episodes can be misdiagnosed as TIAs, he emphasizes the importance of obtaining a brain MRI to exclude a microbleed in the investigation of older individuals with otherwise unexplained transient neurological episodes. Charidimou A. Elderly and forgetful with transient neurological spells: A story of two amyloids? J Neurol Sci 2015;351:1-2.

Dr. England is the editor-in-chief of the Journal of the Neurological Sciences.

 

 

 

WFN Election 2015: Nominating Committee Recommendations

The Nominating Committee of the World Federation of Neurology, having invited nominations for one treasurer and one elected trustee post, both to be filled with effect from the 2015 Annual General Meeting (Council of Delegates) on Nov. 1, recommends the following candidates to the membership:

Recommended candidates:

Treasurer:

  • Prof. Richard Stark (Australia)
  • Prof. Andreas Steck (Switzerland)

Elected Trustee:

  • Prof. Morris Freedman (Canada)
  • Prof. Steven Lewis (USA)

It is open to anyone to make additional nominations by

  • Obtaining the supporting signatures of five or more authorized delegates
  • Submitting the name(s) of the individual(s) in question to the Secretary-Treasurer General, c/o the London Secretariat office, to arrive at least 30 days prior to the date of the Council of Delegates meeting.

WFN at AAN Congress 2015

By Raad Shakir

WFN/AAN leadership meeting 67th Annual AAN Congress, Washington, DC, 2015. From left to right, Gallo Diop, Ralph Sacco, Terence Cascino, William Carroll, Tim Pedley, Catherine Rydell, Raad Shakir, Riadh Gouider, Steve Lewis and Wolfgang Grisold.

WFN/AAN leadership meeting 67th Annual AAN Congress, Washington, DC, 2015. From left to right, Gallo Diop, Ralph Sacco, Terence Cascino, William Carroll, Tim Pedley, Catherine Rydell, Raad Shakir, Riadh Gouider, Steve Lewis and Wolfgang Grisold.

The AAN is the largest single neurological association in the World Federation. The relationship goes back to the inception of the WFN. The WFN would not have existed without the generous assistance of $126,000 from the National Institutes of Health. This was only possible through the efforts of Dr. Pearce Bailey Jr., the first secretary general of the WFN and the second president of the AAN.

The AAN meeting this year was in Washington, DC, attended by 13,000 with a significant percentage of international delegates. There were 2,678 abstracts. The depth and breadth of the topics and the availability of teaching material is impressive.

Annual meetings of the leaderships of both organizations have become a tradition to discuss bilateral relations and international affairs. This year, there were several issues on the agenda, including joint support for African neurologists and full support for the burgeoning Pan American Federation of Neurological Societies bringing together Latin American neurologists. This organization is to encompass all neurological associations in Latin America and represents the Latin American region as one of six WFN regional organizations.

There was discussion on the creation of a Ted Munsat Award for Training and Education. The late Dr. Munsat was a past president of the AAN and chaired the WFN education committee for many years. There was agreement on creation of the fund, and this will be followed by more detailed discussions in the next few months.

The WFN last year created a regional liaison committee chaired by the AAN President Dr. Tim Pedley. This committee met and heard presentations from the six regions of the WFN. Closer collaboration between regions is the purpose of this committee and this is being achieved.

There is no doubt that neurological needs in Africa are paramount, and this was reflected in the leadership meetings and a special Pan African meeting, which was convened by the AAN and attended by stakeholders, including the leaderships of the two organizations and others including Dr. James Bower, Dr. Farah Mateen (chair, Global Health section) and Evelin Sipido representing the European Academy of Neurology with its special interest in annual courses for African neurologists.

Prof. Gallo Diop (Senegal) eloquently presented the needs and offered solutions with measures to ease the huge deficiency of neurologists in Africa. A tentative plan to train neurologists in Africa was discussed with the aim of opening four training centers, two in Francophone and two in Anglophone countries. Rabat and Cairo are already in operation, to be followed by Dakar and Cape Town.

The long-standing partnership between AAN and WFN continues from strength to strength. The AAN and the publisher donate the hard copies to the WFN, and the WFN distributes the course globally. It is now used in 47 countries. Dr. Steve Lewis is the editor and is a WFN co-opted trustee.

At the end of the meeting, Dr. Terence L. Cascino took over as president of the AAN, and Dr. Ralph L. Sacco was elected as president-elect.

No report on the 67th Annual Meeting of AAN could be complete without a special mention of the erudite lecture given by outgoing president Dr. Tim Pedley (link below). The title was “Moving the Academy Forward: Challenges and Opportunities,” and the talk was mesmerizing. His views on neurology as a nonprocedural specialty were spot on. Although the content understandably relates to the U.S. health care system, there are lessons for us all across the world. Indeed, our spectrum and capabilities have markedly improved but the challenges have also grown. The shortage of neurologists in the face of an aging population with increasing numbers of those affected by neurodegenerative diseases is frightening, and in a way it is now recognized by governments as the World Health Organization has emphasized in a recent meeting on dementia that this condition and its cost will cripple world economies in 30 years.

The close ties binding the WFN and the ANN will only grow stronger over the coming years.

https://www.youtube.com/watch?v=ya6mJ3rc2Gs&feature=youtube?

 

 

Redefining Recovery from Aphasia by Dalia Cahana-Amitay and Martin Albert

BOOK REVIEW9780199811939

By Murray Grossman, MD
Cahana-Amitay D and Albert M (2015)
Redefining Recovery from Aphasia
New York: Oxford University Press
281pages, with preface and index

Language is an incredibly complex process. Yet we speak and under- stand effortlessly in order to live our lives daily. The disruption of language following a stroke is a devastating blow to an individual’s day-to-day functioning because of our extreme dependence on this modality of communication. Aphasia is extraordinarily costly to individuals and to society. Nevertheless, aphasia following a stroke is common.

Despite the high cost and common occurrence of aphasia, progress in developing successful treatments for aphasia has been slow. It has proved difficult to demonstrate that traditional speech and language therapies are better at improving communication skills than friendly social interactions. Thus, novel approaches to treatment and recovery from aphasia are desperately needed.

In this timely book, Cahana-Amitay and Albert outline an alternate approach to recovery from aphasia. Their perspective is based on the view that language is not a modular entity, but instead interacts with multiple facets of non-linguistic cognition. This includes domains such as executive functioning, visual processing, attention, memory, emotion and praxis. In turn, the authors observe that brain regions involved in language are highly interconnected with brain regions subserving these other aspects of cognition. The authors coin the phrase “neural multifunctionality” to characterize this multifaceted clinical and functional neuroanatomic approach to language.

In nine chapters, Cahana-Amitay and Albert lay out their approach to language and recovery from aphasia. The first chapter situates their volume in the context of the extensive literature describing recovery from aphasia. The second chapter outlines the authors’ multifunctionality approach to the functional neuroanatomy of language following stroke. In subsequent chapters, Cahana-Amitay and Albert discuss the relationships between language and each of the other domains of cognitive functioning that interact with language. Each chapter defines a domain of cognition, reviews cognitive aspects of the domain and its interaction with linguistic functioning, and then defines the functional neuroanatomy of the cognitive domain. Treatments for aphasia that focus on each domain of cognition are then reviewed.

In the chapter concerned with executive functioning, for example, the authors consider the ways in which language and executive functioning interact, and review disorders of executive functioning observed in aphasic patients such as perseverations, disorders of discourse, and semantic control impairments. Neural correlates of discourse and executive functions in aphasia are then reviewed. The chapter concerned with attention addresses “basic attention” concerned with vigilance and arousal, and “complex attention” selective and alternating attention. After discussing the relationship between attention and language, Cahana-Amitay and Albert examine the neural underpinnings of attention-language interactions and treatments of attention in language.

The chapter devoted to memory examines the role of working memory and other forms of memory in language processing, and the effects of working memory deficits on language functioning. The authors then consider the contribution of memory systems to aphasia treatments and recovery from aphasia as well as learning and anatomic structures implicated in aphasia therapies. In the chapter examining the role of emotion in recovery from aphasia, Cahana-Amitay and Albert examine altered emotions in aphasia, such as depression and anxiety, and interventions focusing on depression and anxiety. The chapter concerned with praxis assesses the breakdown of gesture in aphasia and the intimate connection between gestural and linguistic forms of communication in theories of apraxia. Finally, the authors consider the role of visual processing in recovery from aphasia, including the effects of visual scenes and audiovisual stimulation in language processing, and the role of visually mediated cueing in recovery from aphasia.

In the final chapter, Cahana-Amitay and Albert marshal evidence from the previous chapters to support their neural multifunctionality hypothesis. They conclude that findings from lesion, neuroimaging and electrophysiological studies support their contention that non-linguistic functions need to be incorporated into language models of the intact brain, and that recovery from aphasia must take into account the role of non-linguistic functioning.

Cahana-Amitay and Albert are experienced aphasiologists at the Harold Goodglass Aphasia Research Center of Boston University and the Boston Veterans Administration Medical Center. The authors provide a comprehensive landscape of language and the brain based on functional neuroanatomic theories that have been evolving over the past two decades. The authoritative voice of these authors compels us to reconsider classic approaches to aphasia, and develop novel forms of speech therapy that are organized around the principle of multifunctionality.

Dr. Grossman is professor of neurology, Penn Frontotemporal Degeneration Center, University of Pennsylvania

Editor’s Update and Selected Articles from the Journal of the Neurological Sciences (JNS)

By John D. England, MD

John D. England, MD

John D. England, MD

The Journal of the Neurological Sciences (JNS) is a broad-based journal that publishes articles from a wide spectrum of disciplines, ranging from basic neuroscience to clinical cases. Because JNS is the official journal of the World Federation of Neurology (WFN), the Editorial Board welcomes submissions from around the world. We also strive to publish papers with unique and original observations. In order to satisfy this latter goal, only the best manuscripts are accepted for publication in JNS.

I frequently receive correspondence asking why manuscripts are rejected. The most frequent reason for rejection is that the manuscript does not receive a high enough priority score when the scientific methodology and conclusions are assessed. In view of these criteria for acceptance, my first advice to authors is to design and perform their scientific studies in as rigorous and as thorough a manner as possible. Additionally, original and novel observations are more likely to attain higher scores by reviewers.

As a last but very important point, authors should write the manuscript as clearly and concisely as possible. The English syntax and grammar should be polished and well-edited. When we receive manuscripts that are poorly written, we always send them directly back to the authors for revision prior to more formal review. We cannot publish manuscripts that are poorly written even if the underlying scientific methodology and observations are sound.

JNSJanWe recognize that English is not the native language of many of our authors, and we will allow re-submission of manuscripts that require editing. My suggestion for authors is to have their manuscripts edited by someone who has excellent command of the English language. If you do not have ready access to such a person, please utilize one of the many excellent “English editing” services. In fact, Elsevier will provide this online service to authors for a modest fee.

In our ongoing attempt to enhance accessibility of JNS articles to members of the WFN, we have selected two more “free-access” articles, which are profiled in this issue of World Neurology.

1) Aaron Berkowitz, et al., provide a well-written and richly referenced review on the neurologic manifestations of neglected tropical diseases (NTDs). They focus the review on 17 diseases that the World Health Organization has designated neglected tropical diseases. These diseases disproportionately affect the world’s poorest populations and cause significant morbidity and mortality. In fact, at least 1 billion people around the world are affected by these diseases. Most of these diseases have significant neurologic manifestations. Importantly, these diseases can be controlled using relatively low-cost but strategic plans.
Berkowitz AL, Raibagkar P, Pritt BS, Mateer FJ. Neurologic manifestations of the neglected tropical diseases. J Neurol Sci. 2015;349:20-32.

2.) Edward Mader, et al., provide an interesting and unique case description of a young woman with biopsy-proven tumefactive multiple sclerosis and acute hepatitis C virus 2a/2c who was successfully treated with interferon beta-1a. Although this report is based upon only one case, the observations are potentially very important. The report raises the possibility that a link exists between hepatitis C infection and multiple sclerosis, and it also suggests that interferon beta-1a may be effective treatment for some patients with hepatitis C infection. One particularly reasonable suggestion is that patients with acute CNS demyelination be screened for hepatitis.
Mader EC, Richeh W, Ochoa JM, Sullivan LL, Gutierrez AN, Lovera JF. Tumefactive multiple sclerosis and hepatitis C virus 2a/2c infection: Dual benefit of long-term interferon beta-1a therapy? J Neurol Sci. 2015;349:239-242.

Dr. England is the editor-in-chief of the Journal of the Neurological Sciences.